Brief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Tue 23:02
BRIEF-Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment Oct 20 (Reuters) - Zoetis Inc ZTS.N:
ZOETIS RECEIVES FDA APPROVAL FOR CONVENIA® RTU FOR DOGS (CEFOVECIN INJECTABLE SUSPENSION), HELPING MORE MEDIUM AND LARGE DOGS ACCESS SINGLE-INJECTION TREATMENT
ZOETIS - CONVENIA RTU FOR DOGS EXPECTED TO BE AVAILABLE TO VETERINARIANS IN Q1 2027
Source text: ID:nBw7BhkjGa
Further company coverage: ZTS.N
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies